Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ketamine hydrochloride, quantity: 115.34 mg/ml (equivalent: ketamine, qty 100 mg/ml) - injection, solution - excipient ingredients: water for injections - ketamine is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures;,2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents;,3. to supplement low-potency agents, such as nitrous oxide.

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

duopharma (singapore) pte ltd - ketamine hcl 57.7 mg/ml eqv ketamine - injection - 50 mg/ml - ketamine hcl 57.7 mg/ml eqv ketamine 50 mg/ml

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

actavis pharma, inc. - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 5 mg - memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of memantine hydrochloride in pregnant women. adverse developmental effects (decreased body weight, and skeletal ossification) were observed in the offspring of rats administered memantine during pregnancy at doses associated with minimal maternal toxicity. these doses are higher than those used in humans at the maximum recommended daily dose of memantine hydrochloride [see data].    in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

ajanta pharma usa inc. - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 5 mg - memantine hydrochloride usp is indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride is contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of memantine hydrochloride in pregnant women. adverse developmental effects (decreased body weight, and skeletal ossification) were observed in the offspring of rats administered memantine during pregnancy at doses associated with minimal maternal toxicity. these doses are higher than those used in humans at the maximum recommended daily dose of memantine hydrochloride [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. data a

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - ketamine hydrochloride 115.34 mg/ml equivalent to ketamine 100 mg/ml - solution for injection - 100 mg/ml - active: ketamine hydrochloride 115.34 mg/ml equivalent to ketamine 100 mg/ml excipient: nitrogen water for injection - ketamine-baxter is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine-baxter is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

biomed limited - ketamine hydrochloride 11.53 mg/ml equivalent to 10 mg/ml ketamine;   - solution for infusion - 10 mg/ml - active: ketamine hydrochloride 11.53 mg/ml equivalent to 10 mg/ml ketamine   excipient: sodium chloride water for injection - ketamine infusion is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

biomed limited - ketamine hydrochloride 1.153 mg/ml equivalent to 1 mg/ml ketamine;   - solution for infusion - 1 mg/ml - active: ketamine hydrochloride 1.153 mg/ml equivalent to 1 mg/ml ketamine   excipient: sodium chloride water for injection - ketamine infusion is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

biomed limited - ketamine hydrochloride 2.307 mg/ml equivalent to 2 mg/ml ketamine - solution for infusion - 2 mg/ml - active: ketamine hydrochloride 2.307 mg/ml equivalent to 2 mg/ml ketamine excipient: sodium chloride water for injection - ketamine infusion is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

biomed limited - ketamine hydrochloride 4.613 mg/ml equivalent to 4 mg/ml ketamine - solution for infusion - 4 mg/ml - active: ketamine hydrochloride 4.613 mg/ml equivalent to 4 mg/ml ketamine excipient: sodium chloride water for injection - ketamine infusion is recommended: 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Նոր Զելանդիա - անգլերեն - Ministry for Primary Industries

ceva animal health (nz) limited - ketamine hydrochloride - ketamine hydrochloride 115.6 g/litre - anaesthetic